JPRN-UMIN000001191
已完成
2 期
A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma. - Inducion and maintenance therapy by rituximab for low grade B cell lymphoma.
Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)0 个研究点目标入组 42 人2008年6月20日
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- low grade B cell lymphoma
- 发起方
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 入组人数
- 42
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\.presence of central nervous invasion(clinical or pathological). 2\.transformed patients (clinical or pathological). 3\.past history of glaucoma. 4\.past history of severe drug allergy. 5\.HIV Ab positive or HTLV\-1 Ab positive. 6\.HBsAg positive, HBsAb positive, or HCV Ab positive. 7\.severe cardiac disease 8\.hepatic cirrhosis 9\.uncontrollable diabetis melitus 10\.patients with dialysis 11\.lung fibrosis or interstitial pneumonitis 12\.other active malignancies 13\.pregnant or feeding female 14\.severe mental disorder 15\.systemic therapy with corticosteroid 16\.judged for inappropriate with other reasons.
结局指标
主要结局
未指定
相似试验
已完成
2 期
Phase II study of remission induction therapy with bendamustine and rituximab combination (BR) therapy followed by consolidation therapy with 90Y-labeled iburitumomab tiuxetan for relapsed follicular lymphoma.(BRiZ2012 protocol)follicular lymphomaJPRN-UMIN000008793Society of Lymphoma Treatment in Japan (SoLTJ)28
终止
2 期
A programme of development for older patients with acute myeloid leukaemia and high risk myelodysplastic syndromeAcute myeloid leukaemia (AML)myelodysplastic syndromeCancer - Leukaemia - Acute leukaemiaBlood - Haematological diseasesACTRN12612000848808Australasian Leukaemia and Lymphoma Group60
尚未招募
不适用
Prediction of therapeutic efficacy of ulcerative colitis based on gene expression in the colonic mucosa.ulcerative colitisJPRN-UMIN000050517Kyoto Prefectural University of Medicine100
进行中（未招募）
1 期
Evaluation of the impact of remission induction chemotherapy prior to allogeneic stem cell transplantation in relapsed and poor-response patients with AMEUCTR2014-003124-44-DEDKMS gemeinnützige GmbH308
已完成
不适用
Study of the utility of acute-phase and remission maintenance therapy with 2.5% benzoyl peroxide gel for moderate or severe acne vulgarisAcne vulgarisJPRN-UMIN000019639on-Profit Organization Health Institute Research of Skin180